Tuesday, November 21, 2017
Biosynthesis Breakthrough CBD Pharmaceuticals

Vitality Biopharma, Inc. (OTCQB: VBIO) Rallies 18.94% Announces CBD Pharmaceutical Biosynthesis Breakthrough

Vitality Biopharma, Inc. (OTCQB: VBIO) is engaged as a CBD-based pharmaceutical developer. Shares of the biopharmaceutical company are rallying 18.94%, through afternoon trading on...
Clinical Trial Study Results TB

CURE Pharmaceutical Holding Corp. (OTCQB: CURR) Rallies 14.80% After Results of Bioequivalence Study of...

CURE Pharmaceutical Holding Corp. (OTCQB: CURR) is engaged as a proprietary drug dosage delivery system. Shares of the specialty bioscience company are climbing 14.80%,...
Medical Cannabis Specialty Pharmaceuticals Partnership

UNIVEC, Inc. (OTC Pink: UNVC) Surges 68.42% Announces Cannabis Oil Partnership With AGRiMED Industries

UNIVEC, Inc. (OTC Pink: UNVC) is engaged as a specialty pharmaceutical company. Shares of the pharmaceutical manufacturer are surging 68.42%, through early trading on...
Bankruptcy Court Approves Plans for Reorganization

Adeptus Health, Inc. (OTC Pink: ADPTQ) Increases 5.77% After Plan of Reorganization Approved by...

Adeptus Health, Inc. (OTC Pink: ADPTQ) is the largest operator of freestanding emergency rooms across the United States. Shares of the healthcare provider are...
Medical Device SPORT Surgical Feasibility Studies Medical

Titan Medical, Inc. (OTCQB: TITXF) Rallies 14.88% After Partnering with Columbia University Medical Center...

Titan Medical, Inc. (OTCQB: TITXF) is a medical device company that is engaged within the design, development, and commercialization of robotic surgical systems. Shares...
The MicroCap Conference Presentation

MRI Interventions, Inc. (OTCQB: MRIC) Rallies 13.18% After Announcing Presentation at The MicroCap Conference...

MRI Interventions, Inc. (OTCQB: MRIC) is engaged as a medical imaging and technology developer and distributor. Shares of the medical technology company are gaining...

International Stem Cell Corp. (OTCQB: ISCO) Gains 12.42% After Moving Forward with Phase 2...

International Stem Cell Corp. (OTCQB: ISCO) is engaged as a stem cell therapeutics company. Shares of the stem cell treatment developer are rallying 12.42%,...
Prostate Cancer Vaccine Treatment Primary Objective OncBioMune Pharmaceuticals

OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) Jumps 47.61% After Meeting Primary Objective in Trial for...

OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) is engaged as a biopharmaceutical company that develops proprietary treatments for cancer and other diseases. Shares of the medical...
Preclinical Information Presentations Vaccinations

Mymetics Corp. (OTCQB: MYMX) Climbs 21.58% After Plans to Present New Preclinical Data on...

Mymetics Corp. (OTCQB: MYMX) is engaged within the research, development, and commercialization of virosome-based vaccinations to treatment infectious diseases. Shares of the medical company...
CBD-based Biosynthesis Provisional Patent Filing

InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) Rallies 11.11% After Filing Provisional Patent For Biosynthesis of...

InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) is engaged as a biopharmaceutical company that specializes in CBD-based treatments. Shares of CBD-based treatment developer are rallies 11.11%,...

STAY CONNECTED

128,486FansLike
1,260FollowersFollow
1,058FollowersFollow
137SubscribersSubscribe

MOST POPULAR